GlaxoSmithKline PLC — Director's Dealing 2016

Mar 30, 2016

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 6141T

GlaxoSmithKline PLC

30 March 2016

GlaxoSmithKline plc

Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

In accordance with DTR 3.1.4R (1) (a) I give details of changes in the interests of Persons Discharging Managerial Responsibilities ("PDMR's"), in the Ordinary Shares of GlaxoSmithKline plc (the "Company") as follows:

PDMR	Transaction
C Thomas	The sale of 17,000 Ordinary Shares on 30 March 2016 at a price of £14.08 per share.
P Vallance	The exercise of a nil priced option over 33,406 Ordinary Shares on 30 March 2016, granted on 28 February 2013, which vested on 28 February 2016 under the GlaxoSmithKline Deferred Annual Bonus Plan. The sale of 24,251 Ordinary Shares on 30 March 2016 at a price of £14.12. The sale of 9,155 Ordinary Shares on 30 March 2016 at a price of £14.11.

The Company and the above-mentioned PDMR's were advised of these transactions on 30 March 2016.

V A Whyte

Company Secretary

30 March 2016

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSQBLFXQXFZBBD

//<![CDATA[$.ajaxSetup({headers: {'__RequestVerificationToken':'bFSDOTa1VsjOIBIexDqK5xngBZOfeyA8bUnq7MlU-Ztvav9TL3Vti_RmQSsVid5ZNJsPe_rE8Q4QtZidAIfc98fY8l3UaCwTuXRCynsN6_81:rB39c9-cNmQnbe0RcBVy3TDqb17UTGM44mW55GFlEkNOFMyof9dxbY64-qNeKPgvhzFDZw_rD6QhZaNheF75EfMPvADefP8kTM4bKAlSR1A1'}});//]]>